Posts

Showing posts from April, 2024

Let us talk about Pomalidomide & generic pomalidomide

  Pomalidomide (Pomalyst) Cost Pomalidomide is a kind of prescription medication that is used for the treatment of people that are suffering from multiple myeloma. It is a type of blood cancer that can arise from the bone marrow cells. Pomalidomide is prescribed to patients whose cancer levels have progressed even after being treated with other medications. The cost of Pomalidomide is a bit high but considering the effectiveness of the medication, it is worth it to continue with the dosage. Pomalidomide is sold as a generic medication and also as a brand-name medication under the name of Pomalyst.  The medication comes in the form of a capsule and should be taken once daily and that too on an empty stomach. Swallow the pomalidomide capsules with water while. Some of the common side effects, dosage information, and availability information about the medication are provided below in detail. If we talk about Pomalidomide cost , then it is really not pocket friendly for poor p...

Exploring Ibrutinib cost in USA

  The new anti-cancer drug ibrutinib (Imbruvica), developed by the J & J pharmaceutical company is significantly more effective than standard chemotherapy for leukemia. This is evidenced by the results of clinical studies published in The Daily Mail. During the trial, some patients with chronic lymphocytic leukemia received ibrutinib, and some patients received chemotherapy. It turned out that in the first group the survival rates were 90%, in the chemotherapy group - 81%. The researchers note that in the group of participants receiving ibrutinib, remission rates were in four out of ten patients, in the chemotherapy group - four out of a hundred. It should also be noted that patients responded more quickly to ibrutinib than to chemotherapy. Another advantage of the new drug over chemotherapy is the fewer side effects associated with its use. Scientists believe that ibrutinib can replace standard chemotherapy. It is especially indicated for patients who have developed resistance...